ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 8,600 | $396,718 | 0.00% |
| LPL Financial LLC | 7,434 | $342,930 | 0.00% |
| PRIVATE TRUST CO NA | 54 | $2,491 | 0.00% |
| Global Retirement Partners, LLC | 52 | $2,399 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,257 | $57,985 | 0.00% |
| UMB Bank, n.a. | 434 | $20,020 | 0.00% |
| Walleye Trading LLC | 300 | $13,839 | 0.00% |
| Walleye Trading LLC | 3,000 | $138,390 | 0.00% |
| Walleye Trading LLC | 3,000 | $138,390 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,000 | $691,950 | 0.00% |
| STIFEL FINANCIAL CORP | 5,497 | $253,578 | 0.00% |
| BANK OF MONTREAL /CAN/ | 4,739 | $229,083 | 0.00% |
External links
This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q2 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.